Who it is for
Research scientists and informatics teams working in Revvity Signals.
AI Connectors · Healthcare & Life Sciences
Natural language access to the Signals electronic lab notebook
Overview
Revvity Signals is an electronic laboratory notebook and scientific data platform, with ChemDraw and BioDesign alongside it. This connector is described as a natural language route into that estate, covering experiments, compounds, sequences, materials and results, and producing summaries, comparisons and reports grounded in the tenant's own records and their workflow context. One tool is declared. No endpoint URL appears on the listing, so there is nothing here to call and the entry documents an intent rather than a reachable server. The connector holds the partner tier and links to documentation.
Research scientists and informatics teams working in Revvity Signals.
With no endpoint URL published, no request could be made at all, and the single declared tool is recorded on the listing without any way to confirm it.
Availability
Revvity Signals AI is listed in the Claude connectors directory only. Revvity Signals has no app under the same domain in the ChatGPT directory; 392 of the 3,150 products here are on both marketplaces, and this is not one of them.
The MCP server behind a Claude connector is usually the same server a ChatGPT app would need, so the absence is a distribution decision rather than a technical one.
Claude listing
Revvity Signals AI publishes 1 tool to Claude, a deliberately narrow surface; only 0.7% of the 1,253 Claude-listed connectors expose fewer.
The median Claude-listed connector filed under Healthcare & Life Sciences publishes 6, so this one sits 5 tools below its bucket's median, 49th of 51.
It falls in the 1-3 tools band, which holds 16.4% of the Claude directory.
Revvity Signals AI's Claude listing does not publish an endpoint URL. 48 of the 1,253 Claude listings are in the same position: real listings with documentation but no URL in the directory record, so the endpoint has to come from the publisher's own docs.
Every connector in the Claude directory is remote, all 1,253 of them, so transport is not a differentiator there.
Revvity Signals AI carries partner verification in the Claude directory, which 474 of 1,253 listings do (37.8%). That is a review step past self-publishing, not an Anthropic-built server.
In the publisher's words
Connect Claude.AI assistants to the Revvity Signals scientific intelligence platform. The Signals AI MCP Server combines foundation-model reasoning with trusted scientific intelligence from Signals, ChemDraw, BioDesign and related scientific systems, enabling natural-language interaction with experiments, compounds, sequences, materials and scientific results. Go beyond search to generate insights, summaries, reports, comparisons and recommendations grounded in trusted scientific data, provenance and workflow context, turning information into understanding, decisions and action.
Quoted from the connector's own Claude directory listing as captured in August 2026. Node8 did not write it and does not vouch for it.
Nearby
Benchling research data through its own scientific AI chat
Claude
Preprint search across bioRxiv and medRxiv
Claude
Bioactivity, targets and mechanism data from the ChEMBL database
Claude
Search ClinicalTrials.gov by condition, sponsor, investigator or eligibility
Claude
Medicare Part B coverage determinations from the CMS database
Claude
ICD-10-CM and ICD-10-PCS lookup, search and validation
Claude
This is an independent catalogue entry compiled by Node8 from Revvity Signals AI's public marketplace listing as it stood in August 2026. Listing facts come from the marketplaces; the comparisons against the rest of the directory and any live-endpoint measurements are Node8's. Node8 is not affiliated with Revvity Signals, and inclusion here is not an endorsement.
Node8 builds MCP servers end to end: deciding which tools are worth exposing, the authentication and permission model, the review submissions, and the onboarding that gets them used. One server serves ChatGPT, Claude, and Microsoft Copilot.